BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2012
View Archived Issues
Oxygen Biotherapeutics provides update on preclinical Oxycyte studies
Read More
Solute carrier family 12 member 2 expression linked to presbycusis
Read More
Amarantus' MANF demonstrates superiority over GDNF in vivo
Read More
Theraclone Sciences begins phase II viral challenge study for TCN-032
Read More
Results of alisertib phase I/II cancer trial presented
Read More
Dosing commences in phase Ib/IIa study of KD-020
Read More
Chugai enters Japanese license agreement for CSG-452
Read More
Hokusai-VTE phase III trial reaches full enrollment
Read More
Novartis presents results of phase Ib trial of PI3K pathway inhibitors in advanced solid tumors
Read More
New GPR119 receptor agonists disclosed by Arena Pharmaceuticals
Read More
Boehringer Ingelheim patents novel DP2 receptor antagonists
Read More
Universitat Stuttgart presents new fusion proteins
Read More
Novel bispecific antibodies patented by Boehringer Ingelheim
Read More
Prostetta Antiviral discloses novel agents for viral infections
Read More
GlaxoSmithKline synthesizes new LSD1 inhibitors
Read More
Gilead provides results for third quarter of 2012
Read More
Results of phase II COPD trials presented for GSK-573719
Read More
AstraZeneca reports third quarter 2012 results
Read More
bluebird bio receives CIRM grant for lentivirus-mediated gene therapy trial
Read More
FDA approves Synribo for chronic myelogenous leukemia
Read More
FDA turns down request for appeal on NDA for vaginal gel in preterm birth
Read More
Bristol-Myers Squibb reviews highlights of third quarter 2012
Read More
Vaccinex presents in vivo data for its novel anti-CXCL13 antibody
Read More
Sandoz commences trial of biosimilar epoetin alfa
Read More
